Free Trading + Demat + Mutual Fund + 0 AMC

Free Trading + Demat + Mutual Fund + 0 AMC
Click the image to open account

Friday, December 13, 2019

Company Update 13.12.19

BGR ENERGY

The Company was awarded a contract by Tamil Nadu Generation and Distribution Corporation Limited (TANGEDCO) for execution of of 1x660 MW Supercritical Ennore Thermal Power Station Expansion Project under EPC basis. The Scope of contract includes design, engineering and supply of all equipment, civil works, erection, testing and commissioning of all systems and performance guarantee of power plant.

The total value of the project is Rs.4442. 75 Crores (Rupees Four thousand four hundred forty two crores and seventy five lakhs only) including all taxes and duties to complete the contract. The overall contract completion period is 36 months from the date of Letter of Intent. The contract provides for payment in foreign currency for imported items up to USD 114.49 million and adjustment of price due to change in rates of taxes and duties.

The Company's current order book is Rs. 8460 Crores including this contract.

ERIC LIFESCIENCE

The Company had made a public announcement dated 4th July, 2019 published on 5th July, 2019 (“Public Announcement”) for Buyback of its Equity Shares of upto 1,739,130 (One Million Seven Hundred Thirty Nine Thousand One Hundred and Thirty) equity shares of face value of Re. 1/- each fully paid up at a price of Rs. 575/- (Rupees Five Hundred Seventy Five only) per Equity Share aggregating upto Rs. 1,000 Million. The relief from the applicability of buyback tax previously extended by the Government to the listed companies which had made a public announcement ‘before 5th July 2019’ has, in terms of the language of the Taxation Act December 2019, become available to companies which had made a public announcement ‘on or before 5th July 2019’ (thereby covering the Public Announcement made by the Company)

GRANULES INDIA

Company has entered into an agreement with Hubei Biocause Heilen Pharmaceutical CO., Limited., Joint Venture Partner for sale of 33,000,000 equity shares of 1 RMB each fully paid-up held by the Company in Granules-Biocause Pharmaceutical Co. Limited for a consideration of RMB 109 million. Conclusion of this transaction is subject to fulfillment of certain closing conditions as well as applicable regulatory approvals.

KARNATAKA BANK

Karnataka Bank, as part of its digital initiative today launched KBL Xpress Car Loan, a digitized version of Car Loan Finance.

Introduction of KBL Xpress Car Loan allows in-principle sanctions under 20 minutes at customers choice of place and time. This technology enabled solution has additional digital capabilities to provide end-to-end best in class customer experience. Customers KYC authentication, Bureau score , Income , Risk assessment etc will be performed on real time basis which enables a hassle free and complete digital loan sanction.

``With the launching of KBL Xpress Car Loan digital product, Karnataka Bank has now acquired capabilities to sanction car loans within 20 minutes and customer will have a seandess digital journey experience and I am sure that this new scheme will emerge as one of the most popular loan products of the Bank" said Shri Mahabaleshwara in S, MD & CEO of the Bank.

MAGMA FINCORP

Magma Fincorp Limited today announced that the company has raised INR 350 Crore by way of Non- Convertible Debentures (NCDs) from Nederlandse Financierings Maatschappij Voor Ontwikkelingslanden N.V. (FMO), a Dutch Entrepreneurial Development Bank, to support the company’s on-going growth plans. The NCDs issued on a private placement basis are unlisted, redeemable, senior secured and transferable.

This investment by FMO is under Voluntary Retention Route (VRR) for investment in Indian debt by FPI. Proceeds of the NCDs shall be utilized for the company’s ongoing business operations including expansion and growth of its micro and small and medium enterprise (MSME) loan portfolio.

MASTEK

"Mastek sell its partial stake in Majesco to drive growth rate~.

MASTEK confirmed the partial sale of its legacy shareholding in Majesco, USA. initial 2,000,000 Share· were sold for USD 15.94 Mn and the balance of 3,044,875 is intended to be old in en uing future The net proceeds from the sale will be reinvested into the growth of Mastek as part or its committed Vision 2020 strategy.

METROPOLIS HEALTHCARE

 Company has won the Patient Experience Team of the Year Award on December 11 , 2019 by Patient Experience Excellence Awards 2019 held at hotel Shangri La, New Delhi

The award was jointly organised by The Indian Chamber of Commerce and CRM Academy of Asia

ZENSAR TECHNOLOGIES

Zensar participates in the ‘Women in the Workplace 2019’ report by McKinsey and LeanIn.Org

At Zensar, our women workforce happens to be one of our consistent top talent. We have worked toward creating an increasing number of women leaders across all functions at all our worldwide locations. To be included in this report underlines our initiatives towards this important corporate strategy.”

Zensar has created clear career paths for its existing and new women associates. To bring back experienced mid-level women workforce after career breaks, the program, ‘Enliven’, was launched. This initiative focuses on identifying women in technology in India who have taken career breaks and are wanting to return to work, providing internship opportunities and onboarding them full time with relevant upskilling avenues.

In America, which is the company’s biggest market, women associates have been hired at manager and senior positions, making it one of the key areas of focus for the HR function.